| dc.relation | /*ref*/Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004; 15: 321-7. 2. Rosa RH, Miller D, Alfonso E C. The changing spectrum of fungal keratitis in South Florida. Ophthalmology. 1994; 101: 1005-13. 3. Tanure MA, Cohen EJ, Sudesh S, Rapuano CJ, Laibson PR.Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia. Pennsylvania. Cornea. 2000; 19: 307-12. 4. Asbell P, Stenson S. Ulcerative keratitis: Survey of 30 years’laboratory experience. Arch Ophthalmol. 1982; 100: 77-80. 5. Dunlop A, Wright E, Howlader S et al. Suppurative corneal ulceration in Bangladesh: A study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust N Z J Ophthalmol. 1994;22: 105-10. 6. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and South India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002; 86: 1211-15. 7. Xie L, Zhai H, Zhao J, Sun S, Shi W, Dong X. Antifungal Susceptibility for Common Pathogens of Fungal Keratitis in Shandong Province, China. Am J Opthalmol. 2008; 146: 260-265. 8. Chang DC, Grant GV, O’Donell C, Wannemuehler KA, Noble- Wang J, Rao C. Multistate Outbreak of Fusarium Keratitis Associated With Use of a Contact Lens Solution. JAMA. 2006;296(8): 953-63. 9. Centers for Disease Control and Prevention. Fusarium keratitis- Multiple sates 2006. MMWR. 2006; 55: 400-1. 10. Sedo S, Iribarne Y, Fossas M, Vendrell C, Ortiz F. Queratitis Fúngica. Annals d’Oftalmologia. 2003; 11(3): 168-175. 11. David V Seal. Ocular infection. Ed. Martin Dunitz; 1998. 12. Booth C. The Genus Fusarium. Kew, Surrey: CMI.; 1971. pp.19-31. 13. Lewis R, Hogan H, Howell A, Safdar A. Progressive fusariosis: unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage- colony stimulating factor for refractory disseminated infection.Leuk Lymphoma. 2008; 49: 163-5. 14. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. ClinMicrobiol Rev. 2007; 20: 695-704. 15. Leventakos K, Lewis R, Kontoyiannis D P. Fungal Infections in Leukemia Patients: How Do We Prevent and Treat Them? CID.2010; 50: 405-15. 16. Safdar A, Armstrong D. Infections in Patients With Hematologic Neoplasms and Hematopoietic Stem Cell Transplantation: Neutropenia, Humoral, and Splenic Defects. CID. 2011; 53(8):798-806. 17. Matsumoto Y, Murat D, Kojima T, Shimazaki J, Tsubota K. The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br JOphthalmol. 2011; 95(10): 1406-9. 18. Vemuganti GK, Garg P, Gopinathan U, Naduvilath TJ, John RK, Buddi R, et al. Evaluation of agent and host factors in progression of mycotic keratitis. Ophthalmology. 2002; 109: 1538-46. 19. Thomas PA, Leck AK, Myatt M. Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi. Br J Ophthalmol. 2005; 89: 1554-8. 20. Garg P, Mahesh S, Bansal AK, Gopinathan U, Rao GN. Fungal infection in sutureless self-sealing incision for cataract surgery. Ophthalmol. 2003; 110(11): 2173-7. 21. Keyhani K, Seedor JA, Shah MK, Terraciano AJ, Ritterband DC.The incidence of fungal keratitis and endophthalmitis following penetrating keratoplasty. Cornea. 2005; 24(3): 288-91. 22. Thomas PA. Fungal infections of the cornea. Eye. 2003; 17(8): 852-62. 23. Eleinen KG, Mohalhal A, Elmekawy H, Abdulbaki A, Sherif AM,El-Sherif RH. Polymerase Chain Reaction-guided Diagnosis of Infective Keratitis – A Hospital-based Study. Current Eye Research. 2012; 37(11): 1005-11. 24. Embong Z, Wan Hitam WH, Yean CY, Abdul NH, Kamarudin B,Zainal SK. Specific detection of fungal pathogens by 18S rRNA gene PCR in microbial keratitis. BMC Ophthalmol. 2008; 8: 7. 25. Kim E, Chidambaram JD, Srinivasan M Lalitha P, Wee D, Lietman TM. Prospective comparison of microbial culture and polymerase chain reaction in the diagnosis of corneal ulcer. Am J Ophthalmol. 2008; 146: 714–23,723. e1. 26. Fitzsimons R, Peters AL. Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis. Am J Ophthalmol.1986; 101:605-8. 27. Ferrer C, Alió JL. Evaluation of molecular diagnosis in fungal keratitis. Ten years of experience. J Ophthalmic Inflamm Infect.2011; 1: 15-22. 28. Franco L. Fusarium spp. En: Díaz F J, Estrada S, eds. Microbiología de las infecciones humanas. 1st ed. Medellín: Colombia; 2007: 696-9. 29. Gaudio PA, Gopinathan U, Sangwan V. Polymerase chain reaction based detection of fungi in infected corneas. Br J Ophthalmol.2002; 86: 755-60. 30. Vengayil S, Panda A, Satpathy G, Nayak N, Ghose S, Patanaik D. Polymerase chain reaction-guided diagnosis of mycotic keratitis: A prospective evaluation of its efficacy and limitations. Invest Ophthalmol Vis Sci. 2009; 50: 152-6. 31. Zloty P. Diagnosis and management of fungal keratitis. American Academy of Ophthalmology. Focal points. 2002; 20(6): 1-13. 32. Prajna NV, Nirmalan PK, Mahalakshmi R, Lalitha P, Srinivasan M. Concurrent use of 5% natamycin and 2% econazole for the management of fungal keratitis. Cornea. 2004; 23(8): 793-6. 33. Pflugfelder SC, Flynn HW, Zwickey TA, Forster RK, Tsiligianni A, Culberston W W, et al. Exogenous fungal endophthalmitis.Ophthalmol. 1988; 95: 19-30. 34. Dursun D, Fernández V, Miller D, Alfonso EC. Advanced Fusarium Keratitis Progressing to Endophthalmitis. Cornea. 2003; 22(4):300-303. | |
